Preliminary results in quantitation of HLA-DRA by real-time PCR: a promising approach to identify immunosuppression in sepsisShow others and affiliations
2013 (English)In: Critical Care, ISSN 1364-8535, E-ISSN 1466-609X, Vol. 17, no 5, article id R223
Article in journal (Refereed) Published
Abstract [en]
Introduction: Reduced monocyte human leukocyte antigen (mHLA)-DR surface expression in the late phase of sepsis is postulated as a general biomarker of sepsis-induced immunosuppression and an independent predictor of nosocomial infections. However, traditional monitoring of mHLA-DR by flow cytometry has disadvantages due to specific laboratory requirements. An mRNA-based HLA-DR monitoring by polymerase chain reaction (PCR) would improve the clinical usage and facilitate conduction of large multicenter studies. In this study, we evaluated an mRNA-based HLA-DR monitoring by quantitative real-time PCR (qRT-PCR) as an alternative method to traditional flow cytometry.
Methods: Fifty-nine patients with sepsis and blood culture growing pathogenic bacteria were studied. Blood samples were collected at day 1 or 2 after admission, for measurement of mHLA-DR by flow cytometry and mRNA expression of HLA-DRA and class II transactivator (CIITA) by qRT-PCR. Blood samples from blood donors were used as controls (n = 30).
Results: A significant reduced expression of mHLA-DR, HLA-DRA, and CIITA was seen in septic patients compared with controls. HLA-DRA mRNA level in whole blood was highly correlated with surface expression of mHLA-DR.
Conclusions: Patients with sepsis display a diminished expression of HLA-DR at the monocyte surface as well as in the gene expression at the mRNA level. The mRNA expression level of HLA-DRA monitored by qRT-PCR correlates highly with surface expression of HLA-DR and appears to be a possible future biomarker for evaluation of immunosuppression in sepsis.
Place, publisher, year, edition, pages
London, United Kingdom: BioMed Central, 2013. Vol. 17, no 5, article id R223
National Category
Medical and Health Sciences Clinical Laboratory Medicine
Research subject
Medicine
Identifiers
URN: urn:nbn:se:oru:diva-34293DOI: 10.1186/cc13046ISI: 000331540900039PubMedID: 24093602Scopus ID: 2-s2.0-84884967732OAI: oai:DiVA.org:oru-34293DiVA, id: diva2:704775
Note
Funding Agencies:
Nyckelfonden (Örebro, Sweden)
Research committee of Örebro County Council
2014-03-132014-03-132024-01-10Bibliographically approved
In thesis